Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FDC-Windhover
Norwalk, CT, USA
- Ownership
- Private
- Employees
- ~150
- Development stage
- Other
01
Overview
FDC-Windhover was a leading provider of business intelligence, analysis, and data for the pharmaceutical, biotechnology, and medical device industries. The entity was formed by the combination of F-D-C Reports, known for regulatory and policy news like "The Pink Sheet," and Windhover Information, known for strategic analysis and deal-making data in publications like "In Vivo." It provided critical insights into drug development, regulatory pathways, and healthcare commercialization. After being part of Elsevier Business Intelligence, the group was acquired by Informa and subsequently integrated into what is now Citeline under Norstella.
- Industry
- Biomedical IT and Biomedical Data Platforms
Beyond the preview
Go deeper on FDC-Windhover.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FDC-Windhover.